(Q43258764)

17 November 2017

title

Structural basis for oseltamivir resistance of influenza viruses (English)

1 reference

17 November 2017

1 reference

J J Skehel

1 reference

17 November 2017

P J Collins

1 reference

17 November 2017

L F Haire

1 reference

17 November 2017

Y P Lin

1 reference

17 November 2017

J Liu

1 reference

17 November 2017

R J Russell

1 reference

17 November 2017

P A Walker

1 reference

17 November 2017

S R Martin

1 reference

17 November 2017

R S Daniels

1 reference

17 November 2017

V Gregory

1 reference

17 November 2017

S J Gamblin

1 reference

17 November 2017

A J Hay

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

17 November 2017

1 reference

inferred from page(s)

published in

Vaccine

1 reference

17 November 2017

1 reference

17 November 2017

1 reference

17 November 2017

page(s)

6317-6323

1 reference

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Rational design of potent sialidase-based inhibitors of influenza virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Oseltamivir resistance during treatment of influenza A (H5N1) infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Resistance of influenza viruses to neuraminidase inhibitors--a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Avian flu: isolation of drug-resistant H5N1 virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

The structural basis for cap binding by influenza virus polymerase subunit PB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Avian influenza. With change in the seasons, bird flu returns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.017

10.1016/J.VACCINE.2009.07.017

7 January 2021

Identifiers

DOI

1 reference

17 November 2017

1 reference